<DOC>
	<DOCNO>NCT01765088</DOCNO>
	<brief_summary>This study conduct help determine whether addition Interferon-alpha ( α-IFN ) , determine sensitized activity Temozolomide ( TMZ ) vivo vitro , give along temozolomide monthly cycle follow radiation , able delay tumor growth , shrink tumor , impact long people newly diagnose high-grade glioma .</brief_summary>
	<brief_title>A Phase III Trial Adjuvant Temozolomide With Without Interferon-alpha Newly Diagnosed High-grade Gliomas</brief_title>
	<detailed_description>This study conduct help determine whether addition Interferon-alpha ( α-IFN ) , determine sensitized activity Temozolomide ( TMZ ) vivo vitro , give along temozolomide monthly cycle follow radiation , able delay tumor growth , shrink tumor , impact long people newly diagnose high-grade glioma . Four week radiotherapy , newly diagnose WHO III-IV glioma patient randomise two group : TMZ group TMZ+ α-IFN group .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Glioma</mesh_term>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Age : 18 year 75 year newly diagnose WHO IIIIV glioma operation radiotherapy Karnofsky Performance Score ≥ 60 Adequate bone marrow , liver renal function Ability subject understand character individual consequence clinical trial Written inform consent anticipate survival ≥2 month Refusal participate study Known hypersensitivity contraindication temozolomide Incompletely radiation Pregnant lactating female Malignant tumor brain tumor Contraindicated MRI examination Unable comply followup study trial Purulent chronic infect wound Uncontrolled psychotic disorder epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>High-grade glioma</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>Temozolomide</keyword>
	<keyword>Interferon-alpha</keyword>
</DOC>